| Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A I Matak, L Bach-Rojecky, B Filipović, Z Lacković Neuroscience 186, 201-207, 2011 | 219 | 2011 |
| Mechanisms of botulinum toxin type A action on pain I Matak, K Bölcskei, L Bach-Rojecky, Z Helyes Toxins 11 (8), 459, 2019 | 194 | 2019 |
| Botulinum toxin A, brain and pain I Matak, Z Lacković Progress in neurobiology 119, 39-59, 2014 | 180 | 2014 |
| Botulinum toxin’s axonal transport from periphery to the spinal cord I Matak, P Riederer, Z Lacković Neurochemistry international 61 (2), 236-239, 2012 | 153 | 2012 |
| Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy B Filipović, I Matak, L Bach-Rojecky, Z Lacković PLoS one 7 (1), e29803, 2012 | 110 | 2012 |
| Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons I Matak, O Rossetto, Z Lacković PAIN® 155 (8), 1516-1526, 2014 | 72 | 2014 |
| Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches Z Lacković, B Filipović, I Matak, Z Helyes British Journal of Pharmacology 173 (2), 279-291, 2016 | 71 | 2016 |
| Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A V Drinovac, L Bach-Rojecky, I Matak, Z Lacković Neuropharmacology 70, 331-337, 2013 | 71 | 2013 |
| Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice I Matak, V Tékus, Z Lacković, Z Helyes Neuroscience 358, 137-145, 2017 | 62 | 2017 |
| Botulinum neurotoxin type A: actions beyond SNAP-25? I Matak, Z Lacković Toxicology 335, 79-84, 2015 | 62 | 2015 |
| Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons M Caleo, M Spinelli, F Colosimo, I Matak, O Rossetto, Z Lackovic, ... Journal of Neuroscience 38 (48), 10329-10337, 2018 | 51 | 2018 |
| Evidence for central antispastic effect of botulinum toxin type A I Matak British journal of pharmacology 177 (1), 65-76, 2020 | 31 | 2020 |
| Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region B Filipović, I Matak, Z Lacković Journal of neural transmission 121, 555-563, 2014 | 30 | 2014 |
| Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats S Ibragić, I Matak, A Dračić, A Smajlović, M Muminović, F Proft, E Sofić, ... Neuroscience letters 617, 213-217, 2016 | 22 | 2016 |
| Botulinum toxin type A in motor nervous system: unexplained observations and new challenges I Matak, Z Lacković, M Relja Journal of neural transmission 123, 1415-1421, 2016 | 12 | 2016 |
| Lasting peripheral and central effects of botulinum toxin type A on experimental muscle hypertonia in rats P Šoštarić, B Vukić, L Tomašić, I Matak International journal of molecular sciences 23 (19), 11626, 2022 | 11 | 2022 |
| Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats I Matak, I Stracenski, Z Lacković Journal of neural transmission 120, 141-144, 2013 | 10 | 2013 |
| Association of intranasal and neurogenic dural inflammation in experimental acute rhinosinusitis L Lovrenčić, I Matak, Z Lacković Frontiers in pharmacology 11, 586037, 2020 | 9 | 2020 |
| Detection of VAMP proteolysis by tetanus and botulinum neurotoxin type B in vivo with a cleavage-specific antibody F Fabris, P Šoštarić, I Matak, T Binz, A Toffan, M Simonato, C Montecucco, ... International journal of molecular sciences 23 (8), 4355, 2022 | 8 | 2022 |
| A hacked kitchen scale-based system for quantification of grip strength in rodents J Homolak, D Virag, I Kodvanj, I Matak, AB Perhoc, A Knezovic, JO Barilar, ... Computers in biology and medicine 144, 105391, 2022 | 7 | 2022 |
Zdravko LackovicProfesor farmakologije, Sveučilište u Zagrebu Medicinski fakultet在 mef.hr 的电子邮件经过验证
